EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Double Q‐Learning for Intelligent Multi‐Drug Scheduling in Cancer Chemotherapy Optimisation

Behnoush Alizade iD, Ahmad Hajipour iD

IET Systems Biology · 2026-01 · 20 (1)

DOI: 10.1049/syb2.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Systems Biology, online erschienen am 03.08.2026. Verfasst von Behnoush Alizade und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Electrical & Computer Engineering, Hakim Sabzevari University, Sabzevar, Iran. Hauptthemen laut MEDLINE: Models, Biological, Neoplasms, Antineoplastic Agents, Machine Learning. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy scheduling poses a challenging control problem due to the need to suppress tumour growth whilst maintaining systemic toxicity within clinically acceptable limits. This study develops a double Q‐learning–based controller for optimising daily dosing of a three‐drug regimen consisting of cisplatin, docetaxel and irinotecan. A pharmacokinetics–pharmacodynamics (PK/PD) tumour model with eight resistance states is used as the simulation environment. The controller aims to minimise tumour burden whilst enforcing strict toxicity constraints aligned with clinical dosing guidelines. Simulation results show that double Q‐learning substantially outperforms classical Q‐learning, achieving near‐complete tumour suppression within the simulation framework, corresponding to a residual tumour fraction on the order of (approximately six orders of magnitude reduction) whilst maintaining toxicity within predefined constraints. Robustness analyses under physiological parameter variations of up to and under abrupt disturbance events further demonstrate that the double Q‐learning policy preserves stable closed‐loop behaviour within the simulation environment and exhibits strong resilience to uncertainty. Overall, the results indicate that double Q‐learning provides a proof‐of‐concept framework for adaptive chemotherapy optimisation, with potential for future investigation in reinforcement learning‐based chemotherapy optimisation frameworks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalNeoplasmsAntineoplastic AgentsMachine LearningHumansComputer SimulationReinforcement Machine LearningIrinotecanDrug Administration Schedule

Stichwörter der Autor:innen

learning (artificial intelligence)medical control systemsnonlinear dynamical systemsoptimal controltumours

Substanzen

Antineoplastic AgentsIrinotecan

Autor:innen und Institutionen

  • Faculty of Electrical & Computer Engineering, Hakim Sabzevari University, Sabzevar, Iran.

ORCID-Profile: Behnoush Alizade, Ahmad Hajipour

Zitieren

APA

Alizade, B., & Hajipour, A. (2026). Double Q‐Learning for Intelligent Multi‐Drug Scheduling in Cancer Chemotherapy Optimisation. IET Systems Biology, 20(1). https://doi.org/10.1049/syb2.70083

Vancouver

Alizade B, Hajipour A. Double Q‐Learning for Intelligent Multi‐Drug Scheduling in Cancer Chemotherapy Optimisation. IET Systems Biology. 2026;20(1). doi:10.1049/syb2.70083

BibTeX
@article{Alizade2026,
  author = {Alizade, Behnoush and Hajipour, Ahmad},
  title = {Double Q‐Learning for Intelligent Multi‐Drug Scheduling in Cancer Chemotherapy Optimisation},
  journal = {IET Systems Biology},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1049/syb2.70083}
}
Kostenlos starten →